News: Aura BRAUN

DELSOL Avocats is proud to be ranked in 11 Legal 500 EMEA 2026 categories : M&A : Smaller deals – Tier 1 The regions – Tier 1 Industry focus : Healthcare and life sciences – Tier 2 Construction – Tier 3 Data privacy and data protection – Tier 3 Private equity : venture/growth capital – Tier 3 Dispute resolution : Commercial litigation – Tier 4...

DELSOL Avocats has advised the AGORiA Santé consortium, in partnership with BIOGROUP, on obtaining the CNIL’s (French data protection authoritys) first authorization to combine biology and SNDS (French national health data system) data in a health data warehouse. Created in 2021, the AGORIA Santé consortium comprises AstraZeneca France, Takeda...

The Draft Economic Life Simplification Bill, passed by the French National Assembly on June 17th, 2025, seeks to promote French innovation in the healthcare sector by easing both the practical conditions for conducting researches in France and the administrative formalities that accompany it. Indeed, the very name of the title - “Simplify to...

DELSOL Avocats advised the Centre Hospitalier Intercommunal Toulon - La Seyne-sur-Mer (CHITS) on the takeover of the Sainte-Marguerite clinic in Hyères (south of France) by Almaviva Santé, a group specialising in private hospital services in France and owned by the Kuwaiti Wren House fund. This takeover is part of a disposal plan approved by...

The decree of February 7, 2025, published in the Official Journal on March 1, expands the list of databases included within the « catalog » of the French National Health Data System (hereinafter referred to as « SNDS »). As a reminder, in accordance with Articles L1461-1 and following of the French Public Health Code, the SNDS is a centralized...

On February 6, 2025, the European Commission published guidelines on the notion of "AI system" [1] ("Guidelines") as defined by article 3(1) of Regulation (EU) 2024/1689 on Artificial Intelligence [2] ("AI Act") and clarified by its Recital 12. As a reminder, the AI Act defines an AI system as "a machine-based system that is designed to...

Artificial intelligence ("AI") is at the heart of medical and technological innovations, but its fast development raises significant ethical and legal questions. The European Union aims to address these concerns through the publication of new guidelines on prohibited AI practices, issued as part of the implementation of Regulation (EU)...

Digital medical devices (hereinafter “DMD”), particularly those incorporating artificial intelligence (hereinafter “AI”) technologies, are developing rapidly in the healthcare sector. To support this development, the competent regulatory authorities are committed to assessing both the safety and efficacy of these DMD. Thus, DMD that are reimbursed...